WESTBURY, N.Y., Aug. 6, 2013 /PRNewswire/ -- Vasomedical,
Inc. (OTC BB: VASO), announced today that it will release its
financial results for the three months ended June 30, 2013 on Tuesday,
August 13, 2013.
The Company will host a conference call the following day on
Wednesday, August 14th at
11:00 a.m. ET featuring remarks by
Jun Ma, Ph.D., President and CEO of
Vasomedical, and Michael Beecher,
Chief Financial Officer of Vasomedical. To dial into the conference
call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669
internationally. All dial-in participants must use the following
code to access the call: 26595138. Please call at least five
minutes before the scheduled start time. The conference call will
also be available via webcast and can be accessed through the
Investor Relations section of Vasomedical's website,
www.vasomedical.com, and www.kcsa.com. Please allow extra time
prior to the call to visit the site and download any necessary
software to listen to the live broadcast.
A replay of the conference call will be available approximately
two hours after completion of the live conference call at
www.vasomedical.com or www.kcsa.com. To access the dial-in
replay of the call, which will be available until September 16, 2013, please dial 1-855-859-2056 or
1-404-537-3406. All dial-in participants must use the following
code to access the call: 26595138.
About Vasomedical
Vasomedical, Inc. is a diversified
medical technology company specializing in the manufacture and sale
of medical devices and in the domestic sale of diagnostic imaging
products. The Company's main proprietary products are
EECP® Therapy systems, the gold standard of ECP
treatment. The Company operates through three wholly owned
subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare.
VasoSolutions manages and coordinates the design, manufacture and
sales of EECP® Therapy systems, and other medical equipment
operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare
is the operating subsidiary for the exclusive sales representation
of GE Healthcare diagnostic imaging products in certain market
segments. Additional information is available on the Company's
website at www.vasomedical.com.
Investor Contacts:
Todd
Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250
tfromer@kcsa.com / grussell@kcsa.com
SOURCE Vasomedical, Inc.